Capstone Investment Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-120,341
Closed -$829K 1835
2021
Q1
$829K Sell
120,341
-9,170
-7% -$77.5K ﹤0.01% 1171
2020
Q4
$1.32M Buy
+129,511
New +$840K ﹤0.01% 997
2019
Q1
Sell
-76,414
Closed -$500K 1347
2018
Q4
$500K Buy
76,414
+47,000
+160% +$527K 0.01% 815
2018
Q3
$507K Sell
29,414
-1,286
-4% -$19.1K 0.01% 796
2018
Q2
$428K Buy
+30,700
New +$518K 0.01% 500
2017
Q2
Sell
-18,600
Closed -$368K 863
2017
Q1
$368K Buy
18,600
+3,768
+25% +$84.1K 0.01% 661
2016
Q4
$357K Buy
+14,832
New +$413K 0.01% 681
2016
Q1
Sell
-10,297
Closed -$307K 746
2015
Q4
$307K Buy
+10,297
New +$347K 0.01% 398

Other funds holding PGEN

Capstone Investment Advisors's PGEN Position: Q2 2021 in Review

Capstone Investment Advisors sold out of Precigen (PGEN) in Q2 2021, closing a stake of 120,341 shares — an estimated $829K sold.

Capstone Investment Advisors first reported a position in PGEN in Q4 2015 and held it in 8 quarters. The position peaked at $1.32M in Q4 2020. 150 funds tracked by Wall St. Rank hold PGEN as of Q2 2021.

  • Capstone Investment Advisors reported no remaining Precigen position as of Q2 2021 after selling out during the quarter.
  • Capstone Investment Advisors sold 120,341 Precigen shares in Q2 2021, an estimated $829K.
  • Capstone Investment Advisors first reported a position in Precigen in Q4 2015 and held it in 8 quarters.
  • Capstone Investment Advisors's Precigen position peaked at $1.32M in Q4 2020.
  • 150 funds tracked by Wall St. Rank held Precigen as of Q2 2021.

Based on Capstone Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.